DoP Study Asks NIPERs To Take Proactive Measures To Promote IPR-Related Research Projects

New Delhi: The National Institutes of Pharmaceutical Education and Research (NIPERs) should take proactive measures to promote and facilitate student participation in intellectual property rights (IPR)-related research projects in order to bridge the academia-industry gap and to achieve self-reliance, according to a study.

The study – Bridging academia-industry gap to achieve self-reliance for NIPER institutions in India – conducted by the Entrepreneurship Development Institute of India for the Department of Pharmaceuticals, based on the research conducted among students, faculty and alumni of NIPERs, observed that only a small group of students were part of any research project related to intellectual property rights (IPR) among NIPER institutions in India.

“This finding suggests that there is a significant gap between industry and academia in the field of pharmaceutical innovation and development. Therefore, we recommend that NIPER institutions take proactive measures to promote and facilitate student participation in IPR-related research projects, such as providing incentives, mentorship, training, and networking opportunities,” it said.

While most students and alumni are well aware of the IPR and Technology transfer, there is still a massive gap in research projects with industry for students.

“Only 17 per cent of the students have previously worked or are currently working with industries on specific assignments and projects. Till academic engagement and classroom pressure are not decreased, the situation will change slowly. Research institutions must provide more freedom for pursuing projects, engagements, research visits, and discussions,” it added.

An analysis of the research reveals a positive trend in creating and protecting intellectual property within the NIPER institutions, added the study. The institutions have actively pursued patent filings for innovative technologies, drug formulations, and processes developed through their research efforts. This emphasis on IPR has strengthened the institutions’ ability to commercialize their innovations and transfer technology to industry partners.

Academic learning for IPR has increased in recent years. Learning from such academic arrangements helps students grow their IPR potential and be confident of infringements. More than 65 per cent of the students have studied a course on IPR. The IPR and its various branches are vital for the country’s
future research and development growth. The percentage can be increased by providing and teaching this course to all the students, the report recommended.

The results of the study indicate that many students and alumni are engaged in IPR related research work and projects. However, 80 per cent of the students and alumni know someone who has been granted a patent recently. This highlights the relevance of the IPR to students and faculty. IPR, in various forms, can be a great source of learning and resources for relevant institutions. There is a need to build and compete with far better countries in this endeavour.

More than 60 per cent of the students know about technology transfer (TT) and technology transfer offices. This kind of knowledge and information proves that students or alumni are well aware and mentally prepared to break into research with industries. Such a thing also needs an academic push, which will help them gain experience through internships and research visits, it added.

Related Posts

  • Pharma
  • October 17, 2024
  • 114 views
CSIR-NIIST To Establish Centres Of Excellence In Ayurveda, Performance Chemicals

Thiruvananthapuram:  The Centre of Excellence in Ayurveda Research to be established on the campus of the CSIR-National Institute for Interdisciplinary Science and Technology (NIIST) at Pappanamcode here is envisaged as…

  • Pharma
  • October 17, 2024
  • 95 views
India, Uzbekistan Discuss Ways To Ensure Quality, Safety In Pharma Sector

New Delhi:  A delegation from Uzbekistan met officials from India’s Central Drugs Standard Control Organisation and discussed areas of collaboration, including the development of a pharmacovigilance system and reducing adverse…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CSIR-NIIST To Establish Centres Of Excellence In Ayurveda, Performance Chemicals

CSIR-NIIST To Establish Centres Of Excellence In Ayurveda, Performance Chemicals

India, Uzbekistan Discuss Ways To Ensure Quality, Safety In Pharma Sector

India, Uzbekistan Discuss Ways To Ensure Quality, Safety In Pharma Sector

Health Worker Arrested For Mixing TB Patient’s Sputum In Doctor’s Food

Health Worker Arrested For Mixing TB Patient’s Sputum In Doctor’s Food

Cipla, Alkem Eye Rs 4,000 Crore Stake In India’s Largest Stent Manufacturer

Cipla, Alkem Eye Rs 4,000 Crore Stake In India’s Largest Stent Manufacturer

DTAB Recommends To Do Away With Toxicity Studies For Intravenous Infusions And Injectables

DTAB Recommends To Do Away With Toxicity Studies For Intravenous Infusions And Injectables

Delhi-Gujarat Haul: Drugs Brought From S America, Purified In Ankleshwar

Delhi-Gujarat Haul: Drugs Brought From S America, Purified In Ankleshwar